<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H3C10528FC11443488F0CAEF199729637" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>116 HR 7757 IH: Long-Term Care Pharmacy Definition Act of 2020</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2020-07-23</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">116th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 7757</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20200723">July 23, 2020</action-date><action-desc><sponsor name-id="S001180">Mr. Schrader</sponsor> (for himself and <cosponsor name-id="M001190">Mr. Mullin</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on <committee-name committee-id="HWM00">Ways and Means</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To codify a statutory definition for long-term care pharmacies.</official-title></form><legis-body id="H68B1BD08E6A749CB9A2DD184624625E1" style="OLC"><section id="HBE6E789F35764D18A46A39B15FC8CBC6" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Long-Term Care Pharmacy Definition Act of 2020</short-title></quote>.</text></section><section id="H5569AB8387814C3DA2122F1E3288CEE7"><enum>2.</enum><header>Definition</header><text display-inline="no-display-inline">Section 1860D–2 of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-102">42 U.S.C. 1395w–102</external-xref>) is amended by adding at the end the following new subsection:</text><quoted-block style="OLC" display-inline="no-display-inline" id="H66A410B532724256A6EC692EFAABC45A"><subsection id="H283D5E4451864E07993D211A9DCE575F"><enum>(f)</enum><header>Long-Term care pharmacy defined</header><paragraph id="H905A233D729840CE9DD2BD3DDD113CAA"><enum>(1)</enum><header>In general</header><text>The term <term>long-term care pharmacy</term> means a pharmacy licensed under applicable State law that is able to provide enhanced pharmacy and clinical services to individuals who require enhanced medication services and reside in a facility (as defined in paragraph (4)).</text></paragraph><paragraph id="H54393BB50C4044CB8362BC12C4A5612A"><enum>(2)</enum><header>Enhanced pharmacy and clinical services</header><text>As used in this subsection, the term <term>enhanced pharmacy and clinical services</term> includes—</text><subparagraph id="H64A79A63DCD84425BFF182BC7D2DEF3F"><enum>(A)</enum><text>medications dispensed pursuant to a prescription or chart order in specialized packaging which shall include unit of use packaging, unit dose packaging, single use containers, packaging from remote automated dispensing technology, or other packaging required;</text></subparagraph><subparagraph id="HA38557E98C7746259265B92A352BAF11"><enum>(B)</enum><text>drug utilization review to identify potential adverse drug reactions and inappropriate drug usage;</text></subparagraph><subparagraph id="H16A0F2D9EEAF488789F6C2EB5200C3F8"><enum>(C)</enum><text>medication reconciliation services at the transition of care and other necessary clinical management and medication services;</text></subparagraph><subparagraph id="HDB8D710F547047F8AF80CB1D10A7A7BA"><enum>(D)</enum><text>timely medication delivery 24 hours a day, 7 days a week;</text></subparagraph><subparagraph id="HFC8FE81370034A579BCD4E07FBC71CB5"><enum>(E)</enum><text>pharmacist on-call availability to provider dispensing and clinical services 24 hours a day, 7 days a week;</text></subparagraph><subparagraph id="H5603C02A6552498E9C25D61545894D85"><enum>(F)</enum><text>emergency supplies of medication as permitted by law and as required, including emergency kits or remote automated dispensing technology at a facility; and</text></subparagraph><subparagraph id="H6D0FC306E2094D608BB286D130EEDA39"><enum>(G)</enum><text>such other services as the Secretary determines appropriate.</text></subparagraph></paragraph><paragraph id="H728B5E524E984A1CAD8E22D2E1E0C6CD"><enum>(3)</enum><header>Individuals requiring enhanced medication services</header><text>As used in this subsection, the term <term>individual who requires enhanced medication services</term> means an individual who has one or more comorbid and medically complex chronic conditions that are life-threatening or significantly limit overall health or function, pose a high risk of hospitalization or other adverse health outcomes, and require enhanced pharmacy and clinical services.</text></paragraph><paragraph id="HF1061F59A62B463A847A4F66C7999B63"><enum>(4)</enum><header>Facility</header><text>As used in this subsection, the term <term>facility</term> includes a facility described in section 1819(a), 1919(a), or 1905(d), or any other setting in which individuals who require enhanced medication services reside as determined by the Secretary.</text></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></section></legis-body></bill> 

